MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program Dec 22 • 3 min read MagicMed Industries Inc. announced today that it has completed the establishment of the psilocybin-derivatives patent portfolio of the PsybraryTM and the launch of the Candidate Selection program.
BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC Dec 21 • 4 min read BetterLife Pharma Inc. announced that the company has completed its acquisition to acquire 100% of the assets in Transcend Biodynamics LLC.
Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program Dec 21 • 5 min read Revive Therapeutics Ltd. announced that it has entered into a non-binding letter of intent to acquire the full rights to PharmaTher Inc.’s intellectual property pertaining to psilocybin.
MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand Dec 18 • 4 min read MagicMed Industries Inc. announced the closing of its upsized and oversubscribed previously announced private placement of units of the company for aggregate gross proceeds of approximately $8.1M.
Tryp Therapeutics Completes Initial Public Offering Dec 17 • 3 min read Tryp Therapeutics Inc. announced the successful closing of its previously announced initial public offering.